BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Rifaximin
1
Rifaximin-α use is associated with improved muscle mass in patients with cirrhosis
4/25/2025 8:23:02 AM | Browse: 36 | Download: 231
2
Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy
11/24/2023 6:10:12 AM | Browse: 202 | Download: 700
3
Evidence-based approach to management of hepatic encephalopathy in adults
4/22/2022 10:52:23 AM | Browse: 484 | Download: 917
4
Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment
3/24/2022 2:13:21 PM | Browse: 498 | Download: 1839
5
Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care
5/14/2020 3:43:04 AM | Browse: 966 | Download: 2226
6
Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study
1/13/2020 11:27:13 AM | Browse: 1000 | Download: 1971
7
Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy
1/3/2020 1:28:57 AM | Browse: 906 | Download: 1711
8
Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
6/27/2019 10:40:37 AM | Browse: 953 | Download: 2251
9
Current and future pharmacological therapies for managing cirrhosis and its complications
2/27/2019 4:11:15 AM | Browse: 1185 | Download: 1793
10
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
12/20/2017 2:49:19 AM | Browse: 1373 | Download: 2447
11
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
7/7/2017 11:41:16 AM | Browse: 1278 | Download: 2051
12
Advances in cirrhosis: Optimizing the management of hepatic encephalopathy
12/10/2015 3:04:00 PM | Browse: 1223 | Download: 1906
13
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver
12/2/2015 12:01:00 PM | Browse: 1448 | Download: 1737
14
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications
11/24/2015 3:55:00 PM | Browse: 1322 | Download: 2208
15
Rifaximin and Crohn's disease
9/12/2014 8:41:00 PM | Browse: 1175 | Download: 1094
16
Clinical update for the diagnosis and treatment of Clostridium difficile infection
9/5/2014 2:44:00 PM | Browse: 1476 | Download: 1430
17
Second and third line treatment options for Helicobacter pylori eradication
9/3/2014 10:14:00 AM | Browse: 1241 | Download: 1142
18
Irritable bowel syndrome: A concise review of current treatment concepts
8/25/2014 5:12:00 PM | Browse: 1202 | Download: 1266
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345